Aperçu des produits pour anti-Polycystic Kidney Disease 1 (Autosomal Dominant) (PKD1) Anticorps

Full name:
anti-Polycystic Kidney Disease 1 (Autosomal Dominant) Anticorps (PKD1)
Chez www.anticorps-enligne.fr sont 59 Polycystic Kidney Disease 1 (Autosomal Dominant) (PKD1) Anticorps de 12 de différents fournisseurs disponibles. De plus, nous expédions Polycystic Kidney Disease 1 (Autosomal Dominant) Kits (7) et Polycystic Kidney Disease 1 (Autosomal Dominant) Protéines (4) et beaucoup plus de produits pour cette protéine. Un total de 72 Polycystic Kidney Disease 1 (Autosomal Dominant) produits sont actuellement listés.
Synonymes:
mFLJ00285, PBP, Pc-1, PC1, Pkcm, PKD, PKD1, Prkcm, TRPP1

Réactivités les plus populaires pour anti-Polycystic Kidney Disease 1 (Autosomal Dominant) (PKD1) Anticorps

Sélectionnez vos espèces et l'application

anti-Human Anticorps:

anti-Mouse (Murine) Anticorps:

anti-Rat (Rattus) Anticorps:

Tous anti-Polycystic Kidney Disease 1 (Autosomal Dominant) Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-Polycystic Kidney Disease 1 (Autosomal Dominant) Anticorps mieux référencés

  1. Human Polyclonal PKD1 Primary Antibody pour IF (p), IHC (p) - ABIN678083 : Chiou, Sang, Cheng, Ho, Wang, Pan: Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors. dans Carcinogenesis 2013 (PubMed)
    Show all 3 references for 678083

Plus d’anticorps contre Polycystic Kidney Disease 1 (Autosomal Dominant) partenaires d’interaction

Human Polycystic Kidney Disease 1 (Autosomal Dominant) (PKD1) interaction partners

  1. A novel mutation of the PKD1 gene has been identified with autosomal dominant polycystic kidney disease in an affected Chinese family.

  2. Annualized median liver growth rates were 1.68, 1.5 and 1.24% for PKD1-T, PKD1-NT and PKD2 (Montrer PKD2 Anticorps) mutations, respectively (P = 0.49), and remained unaffected by the ADPKD genotype when adjusted for age, gender and baseline HtLV.

  3. this study shows that diet-induced obesity links to estrogen receptor (Montrer ESR1 Anticorps)-positive breast cancer progression via LPA (Montrer APOA Anticorps)/PKD-1-CD36 (Montrer CD36 Anticorps) signaling-mediated microvascular remodeling

  4. Isolated polycystic liver disease genes define effectors of polycystin-1 function

  5. mechanical load upregulates expression of Runx2 (Montrer RUNX2 Anticorps) gene via potentiation of PC1 (Montrer PCSK1 Anticorps)-JAK2 (Montrer JAK2 Anticorps)/STAT3 (Montrer STAT3 Anticorps) signaling axis, culminating to possibly control osteoblastic differentiation and ultimately bone formation.

  6. Gly972Arg of PC-1 (Montrer PCSK1 Anticorps) polymorphisms are associated with polycystic ovary syndrome.

  7. cortactin (Montrer CTTN Anticorps) binds to E-cadherin (Montrer CDH1 Anticorps), and that a posttranslational modification of cortactin (Montrer CTTN Anticorps), RhoA (Montrer RHOA Anticorps)-induced phosphorylation by protein kinase D1 (PKD1; also known as PRKD1 (Montrer PRKD1 Anticorps)) at S298, impairs adherens junction assembly and supports their dissolution.

  8. Ten novel mutations in PKD1 gene were identified in 15 Chinese families with polycystic kidney disease.

  9. PKD1 mutations are associated with autosomal dominant polycystic kidney disease.

  10. The novel PKD1 c.8791+1_8791+5delGTGCG mutation has created a new splice site.

Mouse (Murine) Polycystic Kidney Disease 1 (Autosomal Dominant) (PKD1) interaction partners

  1. critical functions of PC1 (Montrer PCSK1 Anticorps) are regulated by its ability to sense cytosolic calcium levels via binding to calmodulin (Montrer Calm2 Anticorps)

  2. cortactin (Montrer CTTN Anticorps) binds to E-cadherin (Montrer CDH1 Anticorps), and that a posttranslational modification of cortactin (Montrer CTTN Anticorps), RhoA (Montrer RHOA Anticorps)-induced phosphorylation by protein kinase D1 (PKD1; also known as PRKD1 (Montrer PRKD1 Anticorps)) at S298, impairs adherens junction assembly and supports their dissolution.

  3. Galpha12 (Montrer GNA12 Anticorps) is required for the development of kidney cysts induced by Pkd1 mutation in mouse autosomal dominant polycystic kidney disease.

  4. PAK-mediated phosphorylation of PKD1 at Ser203 triggers its membrane dissociation and subsequent entry into the nucleus, thereby regulating the phosphorylation of PKD1 nuclear targets, including class IIa histone deacetylases.

  5. Lysophosphatidic acid/PKD-1 signaling leads to nuclear accumulation of histone deacetylase 7 (Montrer HDAC7 Anticorps), where it interacts with forkhead box protein O1 (Montrer FOXO1 Anticorps) to suppress endothelial CD36 (Montrer CD36 Anticorps) transcription and mediates silencing of antiangiogenic switch, resulting in proangiogenic and proarteriogenic reprogramming.

  6. kd1 mutant mice have transcriptional profiles consistent with changes in lipid metabolism and distinct metabolite and complex lipid profiles in kidneys. .. cells lacking Pkd1 have an intrinsic fatty acid oxidation defect and that manipulation of lipid content of mouse chow modifies cystic disease.

  7. Polycystin 1 was overexpressed in M1 cells, no increase in any of these parameters was detected

  8. Our studies demonstrate that PKD1/2 is a key regulator of MVB maturation and exosome secretion, and constitutes a mediator of the DGK alpha (Montrer DGKA Anticorps) effect on MVB secretory traffic.

  9. detected a marked increase in the localization of beta-catenin (Montrer CTNNB1 Anticorps) in the nucleus of crypt epithelial cells in the ileum of PKD1

  10. PKD1 phosphorylates AMPKalpha2 (Montrer PRKAA2 Anticorps) at Ser485/491, thus diminishing AMPK (Montrer PRKAA1 Anticorps) activity.

Polycystic Kidney Disease 1 (Autosomal Dominant) (PKD1) profil antigène

Antigen Summary

This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described.

Alternative names and synonyms associated with Polycystic Kidney Disease 1 (Autosomal Dominant) (PKD1)

  • polycystic kidney disease 1 (autosomal dominant) (PKD1) anticorps
  • polycystic kidney disease 1 homolog (Pkd1) anticorps
  • polycystic kidney disease 1 homolog (human) (Pkd1) anticorps
  • protein kinase D1 (Prkd1) anticorps
  • mFLJ00285 anticorps
  • PBP anticorps
  • Pc-1 anticorps
  • PC1 anticorps
  • Pkcm anticorps
  • PKD anticorps
  • PKD1 anticorps
  • Prkcm anticorps
  • TRPP1 anticorps

Protein level used designations for PKD1

polycystic kidney disease 1 (autosomal dominant) , polycystin 1 , autosomal dominant polycystic kidney disease 1 protein , polycystic kidney disease-associated protein , polycystin-1 , transient receptor potential cation channel, subfamily P, member 1 , polycystic kidney disease protein 1 , autosomal dominant polycystic kidney disease 1 protein homolog , polycystic kidney disease 1 homolog; polycystin-1 , nPKC-D1 , nPKC-mu , protein kinase C mu type , protein kinase C, mu , protein kinase D , serine/threonine-protein kinase D1

GENE ID SPECIES
416553 Gallus gallus
749291 Pan troglodytes
5310 Homo sapiens
606755 Canis lupus familiaris
100516429 Sus scrofa
18763 Mus musculus
24650 Rattus norvegicus
18760 Mus musculus
Fournisseurs de qualité sélectionnés pour anti-Polycystic Kidney Disease 1 (Autosomal Dominant) (PKD1) Anticorps
Avez-vous cherché autre chose?